Product Information
LAMIVUDINE 300 MG TABLET is a generic product labeled by Apotex Corp., priced at $1.3719 per EA under NDC 60505325203. Its NADAC has been published 605 times since Nov 28, 2013.
FDA first approved this application on Dec 2, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Apotex Corp.NDC
60505325203
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA091606FDA Approved
12/2/2011
TE Code
AB
On Market Since
12/2/2011
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 300 MG TABLET has been published 605 times since Nov 28, 2013, and over the history we have for it it has declined 84.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3719 per EA |
|---|---|
| All-time high | $8.5705 (Dec 11, 2013) |
| All-time low | $1.1052 (Jan 22, 2020) |
| 52-week high | $1.3719 |
| 52-week low | $1.2525 |
| Median price | $2.0185 |
| Average price | $3.0055 |
| Largest weekly change | +54.2% (Feb 17, 2021) |
| Weeks tracked | 605 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 300 MG TABLET, manufactured by Apotex Corp., is $1.3719 per EA (NDC 60505325203), effective Aug 19, 2026.
How has the price of LAMIVUDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 300 MG TABLET has declined 84.0%. It has been tracked across 605 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMIVUDINE 300 MG TABLET has ranged from a low of $1.1052 (Jan 22, 2020) to a high of $8.5705 (Dec 11, 2013), with a median of $2.0185 per EA.
Are there cheaper alternatives to LAMIVUDINE 300 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMIVUDINE 300 MG TABLET?
LAMIVUDINE 300 MG TABLET (NDC 60505325203) is labeled by Apotex Corp., and CMS classifies it as a generic product.